Left Atrial Appendage Closure with the WATCHMAN™ Device – An Evidence Based Therapy
Chair: K.-H. Kuck (Hamburg), B. Lauer (Bad Berka)
| (V1131) | Introduction – Stroke prevention for the AF Patient |
|
|
K.-H. Kuck (Hamburg) |
| (V1132) | The WATCHMAN Implant Procedure |
|
|
H. Sievert (Frankfurt am Main) |
| (V1133) | WATCHMAN Pilot Study Data |
|
|
P. Sick (Regensburg) |
| (V1134) | Results of the PROTECT AF and other clinical trials |
|
|
V. Reddy (New York, US) |
| (V1135) | Selecting Patients for LAA Closure |
|
|
B. Schumacher (Bad Neustadt a. d. Saale) |
| (V1136) | Panel Q and A |
|
|
K.-H. Kuck, B. Schumacher, P. Sick, V. Reddy, H. Sievert, B. Lauer (Hamburg, Bad Neustadt a. d. Saale, Regensburg, Frankfurt am Main, Bad Berka; New York, US) |
| (V1137) | Closing Remarks |
|
|
B. Lauer (Bad Berka) |